Padcev 30 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9HE0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,685
Award facts
- Contract value 100% obligated
- $11,684.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,684.64 delivery order to AmerisourceBergen Drug Corp for PADCEV 30 mg vials on December 23, 2025, with an ultimate completion date of January 15, 2026. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. PADCEV (ado-trastuzumab derprertide vedotin) is an oncology pharmaceutical product used in cancer treatment, reflecting the Defense Logistics Agency's critical role in supplying pharmaceutical products to military healthcare systems and the Department of Defense.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp's extensive federal contracting history demonstrates its capability to meet complex federal procurement requirements through competitive awards, supporting critical medical supply needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9HE0?
SPE2DR26F9HE0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26F9HE0 worth?
The government has obligated $11,685 on SPE2DR26F9HE0.
Is contract SPE2DR26F9HE0 an order under another contract?
Yes. SPE2DR26F9HE0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9HE0 competed?
The extent of competition for SPE2DR26F9HE0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award